During the worldwide shutdown in response to the COVID-19 pandemic, many reports emerged of urban wildlife sightings. While these images garnered public interest and declarations of wildlife reclaiming cities, it is unclear whether wildlife truly reoccupied urban areas or whether there were simply increased detections of urban wildlife during this time. Here, we detail key questions and needs for monitoring wildlife during the COVID-19 shutdown and then link these with future needs and actions with the intent of improving conservation within urban ecosystems. We discuss the tools ecologists and conservation scientists can use to safely and effectively study urban wildlife during the shutdown. With a coordinated, multicity effort, researchers and community scientists can rigorously investigate the responses of wildlife to changes in human activities, which can help us address long-standing questions in urban ecology, inspire conservation of wildlife, and inform the design of sustainable cities.Deep-sea mussels of the subfamily Bathymodiolinae are common and numerically dominant species widely distributed in cold seeps and hydrothermal vents. During long-time evolution, deep-sea mussels have evolved to be well adapted to the local environment of cold seeps and hydrothermal vents by various ways, especially by establishing endosymbiosis with chemotrophic bacteria. However, biological processes underlying the establishment and maintenance of symbiosis between host mussels and symbionts are largely unclear. In the present study, Gigantidas platifrons genes possibly involved in the symbiosis with methane oxidation symbionts were identified and characterized by Lipopolysaccharide (LPS) pull-down and in situ hybridization. Five immune related proteins including Toll-like receptor 2 (TLR2), integrin, vacuolar sorting protein (VSP), matrix metalloproteinase 1 (MMP1), and leucine-rich repeat (LRR-1) were identified by LPS pull-down assay. These five proteins were all conserved in either molecular sequences or functional domains and known to be key molecules in host immune recognition, phagocytosis, and lysosome-mediated digestion. Furthermore, in situ hybridization of LRR-1, TLR2 and VSP genes was conducted to investigate their expression patterns in gill tissues of G. platifrons. Consequently, LRR-1, TLR2, and VSP genes were found expressed exclusively in the bacteriocytes of G. platifrons. Therefore, it was suggested that TLR2, integrin, VSP, MMP1, and LRR-1 might be crucial molecules in the symbiosis between G. platifrons and methane oxidation bacteria by participating in symbiosis-related immune processes.

In the early twentieth century, forestry was one of the most important sectors in Norway and an agitated discussion about the perceived decline of forest resources due to over-exploitation was ongoing. To base the discussion on facts, the young state of Norway established

– the world’s first National Forest Inventory (NFI). Field work started in 1919 and was carried out by county. Trees were recorded on 10 m wide strips with 1-5 km interspaces. Site quality and land cover categories were recorded along each strip. Results for the first county were published in 1920, and by 1930 most forests below the coniferous tree line were inventoried. The 2nd to 5th inventories followed in the years 1937-1986. As of 1954, temporary sample plot clusters on a 3 km × 3 km grid were used as sampling units.

The current NFI grid was implemented in the 6th NFI from 1986 to 1993, when permanent plots on a 3 km × 3 km grid were established below the coniferous tree line. As of the 7th inventory in 1994, the NFI is continuoues, and an increasing demand for mapped information. The relatively simple NFI design has proven to be a robust choice for satisfying steadily increasing information needs and concurrently providing consistent time series.

Considerable research efforts towards the integration of remote sensing technologies enable the publication of the Norwegian Forest Resource Map since 2015, which is also used for small area estimation at the municipality level. On the analysis side, capacity and software for long term growth and yield prognosis are being developed. Furthermore, we foresee the inclusion of further variables for monitoring ecosystem services, and an increasing demand for mapped information. The relatively simple NFI design has proven to be a robust choice for satisfying steadily increasing information needs and concurrently providing consistent time series.Today clinicians may diagnose hundreds of people with coronavirus disease 2019 (COVID-19). We report the case of a child with asthma who sought care for COVID-19 symptoms whose condition did not improve despite appropriate treatment for asthma, pneumonia and COVID-19. Further examination revealed a surprising underlying disease. It is important to consider that in pandemics such as COVID-19, because all attention is paid to the disease, underlying hidden causes may be neglected.The novel coronavirus disease 2019 (COVID-19) outbreak started in early December 2019 in the capital city of Wuhan, Hubei province, People’s Republic of China, and caused a global pandemic. The number of patients confirmed to have this disease has exceeded 9 million in more than 215 countries, and more than 480 600 have died as of 25 June 2020. Coronaviruses were identified in the 1960s and have recently been identified as the cause of a Middle East respiratory syndrome (MERS-CoV) outbreak in 2012 and a severe acute respiratory syndrome (SARS) outbreak in 2003. The current SARS coronavirus 2 (SARS-CoV-2) is the most recently identified. Patients with COVID-19 may be asymptomatic. Typical symptoms include fever, dry cough and shortness of breath. Epoxomicin Gastrointestinal symptoms such as nausea, vomiting, abdominal pain and diarrhoea have been reported; neurologically related symptoms, particularly anosmia, hyposmia and dysgeusia, have also been reported. Physical examination may find fever in over 44% of patients (and could be documented in over 88% of patients after admission), increased respiratory rate, acute respiratory disease and maybe decreased consciousness, agitation and confusion. This article aims at presenting an up-to-date review on the pathogenesis, diagnosis and complications of COVID-19 infection. Currently no therapeutics have been found to be effective. Investigational therapeutics are briefly discussed.